Patent Issued for Simulation-based drug treatment planning (USPTO 11857807).

Insightec Ltd. has been granted a patent for a simulation-based drug treatment planning system that aims to temporarily and locally open the blood-brain barrier (BBB) to allow therapeutic agents to reach the brain tissue. The system uses focused ultrasound and microbubble cavitation to disrupt the BBB, and treatment is planned and adjusted through computational simulations. This system has the potential to benefit patients with brain diseases such as infections, neurodegenerative diseases, enzyme defects, and brain cancer. [Extracted from the article]